MedMap
WHO ARE WE?
MedMap helps biomedical innovators move from evidence to market and from molecular ideas to optimized drug candidates through Clinical Validation & Market Access and AI-driven Drug Optimization services.
WHO ARE WE?
MedMap helps biomedical innovators move from evidence to market and from molecular ideas to optimized drug candidates through Clinical Validation & Market Access and AI-driven Drug Optimization services.
We deliver focused solutions for biomedical innovators through three connected business lines:
Clinical Validation
Local clinical evidence generation, KOL engagement, validation planning and performance evidence for MedTech, IVD and SaMD teams.
AI-driven Drug Optimization
Closed-loop DMTA, molecule generation, QSAR, 42-endpoint ADMET-AI, docking and PK/PD simulation for drug discovery teams.
Market Access Platform
A digital market-access platform connecting regional evidence, regulatory pathways, distributors, hospital stakeholders and commercialization workflows across Southeast Asia.
Vision
A future where biomedical innovation reaches patients faster through stronger evidence, smarter optimization and practical market access across Southeast Asia.
Mission
Our mission is to help MedTech, IVD, digital health and biopharma teams de-risk development, validate locally, optimize scientifically and commercialize with confidence.